808 related articles for article (PubMed ID: 25573853)
1. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.
Vengrenyuk Y; Nishi H; Long X; Ouimet M; Savji N; Martinez FO; Cassella CP; Moore KJ; Ramsey SA; Miano JM; Fisher EA
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):535-46. PubMed ID: 25573853
[TBL] [Abstract][Full Text] [Related]
2. Myocardin regulates vascular smooth muscle cell inflammatory activation and disease.
Ackers-Johnson M; Talasila A; Sage AP; Long X; Bot I; Morrell NW; Bennett MR; Miano JM; Sinha S
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):817-28. PubMed ID: 25614278
[TBL] [Abstract][Full Text] [Related]
3. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
[TBL] [Abstract][Full Text] [Related]
4. ABCA1 and HDL
Castiglioni S; Monti M; Arnaboldi L; Canavesi M; Ainis Buscherini G; Calabresi L; Corsini A; Bellosta S
Atherosclerosis; 2017 Nov; 266():8-15. PubMed ID: 28946038
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
[TBL] [Abstract][Full Text] [Related]
6. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
[TBL] [Abstract][Full Text] [Related]
7. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
[TBL] [Abstract][Full Text] [Related]
8. Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability.
Lyon CA; Johnson JL; Williams H; Sala-Newby GB; George SJ
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):195-201. PubMed ID: 19008530
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
11. The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Zhuang J; Luan P; Li H; Wang K; Zhang P; Xu Y; Peng W
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):84-97. PubMed ID: 27879253
[TBL] [Abstract][Full Text] [Related]
12. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
13. Can a vascular smooth muscle-derived foam-cell really change its spots?
Huff MW; Pickering JG
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):492-5. PubMed ID: 25717175
[No Abstract] [Full Text] [Related]
14. Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.
Byon CH; Han T; Wu J; Hui ST
Atherosclerosis; 2015 Aug; 241(2):313-21. PubMed ID: 26062991
[TBL] [Abstract][Full Text] [Related]
15. The P2Y
Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
[TBL] [Abstract][Full Text] [Related]
16. Myocardin: A novel player in atherosclerosis.
Xia XD; Zhou Z; Yu XH; Zheng XL; Tang CK
Atherosclerosis; 2017 Feb; 257():266-278. PubMed ID: 28012646
[TBL] [Abstract][Full Text] [Related]
17. Uremia modulates the phenotype of aortic smooth muscle cells.
Madsen M; Aarup A; Albinsson S; Hartvigsen K; Sørensen CM; Turczynska K; Nielsen LB; Pedersen TX
Atherosclerosis; 2017 Feb; 257():64-70. PubMed ID: 28107707
[TBL] [Abstract][Full Text] [Related]
18. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
20. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
